key: cord-1036269-zkehgzt4
authors: Chatterjee, Saptarshi
title: Ethical communication to patient & society: a critical responsibility in COVID-19 pandemic
date: 2020-12-27
journal: J Med Ethics Hist Med
DOI: 10.18502/jmehm.v13i30.5047
sha: 1cc6e7e928f89622eb0d705e93921629252183cd
doc_id: 1036269
cord_uid: zkehgzt4

nan

Since December 2019, the emergence of the COVID-19 and the consequent pandemic by the World Health Organization (WHO) has been a threat to public health, raising a challenge to the entire society (1, 2) . The challenge faced by scientists, researchers, and clinicians is to find an appropriate solution for the menace of the COVID-19. The scientific and medicinal community has failed to provide any medicine or vaccine up to now. Yet, encouraging results have been reported. In the present situation, responsible and ethical interactions with the patients are expected from the scientific community as well as from society.

Since there is no definite antiviral medicine against COVID-19, clinicians are mostly dependent on supportive therapy to reduce the severity of symptoms. Several medicines such as Hydroxychloroquine and Remdesivir have been applied empirically. Although, none of them have received approval from the USFDA. Remdesivir has received Emergency Use Authorization (EUA) from the USFDA for emergency use in the treatment of suspected or laboratory-confirmed COVID-19 adults as well as adolescents hospitalized with severe symptoms (3) . Therefore, it is the ethical responsibility of the clinicians to update the patient with this information and receive their consent before usage. publish scientific evidence to prevent the creation of misleading information (13) .

The COVID-19 challenge has offered significant introspection in an ethical context especially in terms of providing information to patients and society, at large, to cope with the situation. An urgent response from the scientific and medicinal community can help to overcome the current situation.

There is a current outbreak of Coronavirus (COVID-19) disease

Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)

Fact sheet for healthcare provider emergency use authorization |(EUA) of Veklury® (Remdesivir) for hospitalized paediatric patients weighing 3.5 Kg to less than 40 Kg or hospitalized paediatric patients less than 12 years of age weighing at least 3.5 Kg

Fraudulent Coronavirus disease 2019 (COVID-19) products

AYUSH, modern medicine and the Covid-19 pandemic

Anonymous: COVID-19 book of five

World Health Organization: How to report misinformation online

Exercise caution when sharing medical advice about Coronavirus on social media

Effectiveness of surgical and cotton masks in blocking SARS-CoV-2: a controlled comparison in 4 Patients

Advice on the use of masks in the community, during home care and in healthcare settings in the context of the novel coronavirus (2019-nCoV) outbreak: interim guidance

The proximal origin of SARS-CoV-2

Low-income countries are more immune to COVID-19: a misconception

Covid-19: Scientific journals are now pumping out research faster than ever